The Efficacy and Safety of Apatinib Treatment for Patients with Unresectable or Relapsed Liver Cancer: a retrospective study

Purpose: Liver cancer is insensitive to chemotherapy. Sorafenib is currently the standard treatment for patients with advanced diseases, with mild survival extension and several intolerable drug-related side effects. The establishment of new treatments is an unmet clinical need. The aim of our study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, Liu, Jiali, Chen, Yong, Fang, Han, Xufeng, Hongming, Pan, Weidong, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096375/
https://www.ncbi.nlm.nih.gov/pubmed/30123344
http://dx.doi.org/10.7150/jca.26376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096375/
https://www.ncbi.nlm.nih.gov/pubmed/30123344
http://dx.doi.org/10.7150/jca.26376

Ejemplares similares